Liminal BioSciences is a development-stage biopharmaceutical company focused on GPCR targets. See our social media community guidelines at https://xitter.cf/t.co/g8pxLKM4xp
"The reality for many people living with a severe lung condition is that periods of self-isolation can be quite common. But this is extreme, even for us."
Carol and her daughter are both in shielding, she discusses how they're managing to stay in touch: blf.org.uk/your-stories/my-d…
Here's to the #newyear and to leading healthy, productive, and fulfilling lives with the help of #plasmaprotein therapies! Learn more about how PPTs help improve quality of life among those living with rare diseases: bit.ly/2GBG7ZW
#ASH17: New long-term data exhibiting the safety and efficacy of @Prometic’s plasminogen in patients with congenital plasminogen deficiency were presented this weekend. The results displayed the therapy’s clear clinical benefit.
raredr.com/link/3001